Computational drug discovery pipelines identify NAMPT as a therapeutic target in neuroendocrine prostate cancer

Documenti analoghi

• Proposing a framework to quantify the potential impact of pharmacokinetic drug–drug interactions caused by a new drug candidate by using real world data about the target patient population
  di: Simon Dagenais, et al.
  Pubblicazione: (2024)
• CRISPRi screening identifies PIKfyve as a co‐therapeutic target for obinutuzumab
  di: Yerim Kim, et al.
  Pubblicazione: (2025)
• Age‐related off‐label drug prescribing in pediatric patients in South Korea and consistency of labeling compared to the United States, Europe, and Japan
  di: Bojung Park, et al.
  Pubblicazione: (2024)
• Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer
  di: Sally E. Claridge, et al.
  Pubblicazione: (2025)
• Single‐cell sequencing for cancer precision medicine: From mechanism discovery to diagnosis and therapeutics
  di: Yue Zhao, et al.
  Pubblicazione: (2026)